{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:10:17Z","timestamp":1787069417227,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B20016"],"award-info":[{"award-number":["B20016"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270069"],"award-info":[{"award-number":["82270069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["22JCQNJC01610"],"award-info":[{"award-number":["22JCQNJC01610"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["63231203"],"award-info":[{"award-number":["63231203"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113313","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T02:51:39Z","timestamp":1728528699000},"page":"113313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK\/NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"143","author":[{"given":"Zhichao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5246-5776","authenticated-orcid":false,"given":"Zhigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-3422","authenticated-orcid":false,"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2024.113313_b0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/BOR.0000000000000270","article-title":"Management of connective tissue diseases associated interstitial lung disease: a review of the published literature","volume":"28","author":"Wallace","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113313_b0010","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00296-016-3571-7","article-title":"Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease","volume":"36","author":"Obert","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.intimp.2024.113313_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","article-title":"Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease","volume":"194","author":"Johnson","year":"2016","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.intimp.2024.113313_b0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.113313_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102245","article-title":"Treatment approach to connective tissue disease-associated interstitial lung disease","volume":"65","author":"Wilson","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2024.113313_b0030","doi-asserted-by":"crossref","first-page":"1051609","DOI":"10.3389\/fimmu.2022.1051609","article-title":"Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis","volume":"12","author":"Zhen","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113313_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11523-021-00857-8","article-title":"Bruton tyrosine kinase inhibitors in B-cell malignancies: their use and differential features","volume":"17","author":"Shirley","year":"2022","journal-title":"Target. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113313_b0040","article-title":"Bruton's tyrosine kinase (BTK) inhibitors and autoimmune diseases: making sense of BTK inhibitor specificity profiles and recent clinical trial successes and failures","volume":"3","author":"Ringheim","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113313_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109138","article-title":"Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization","volume":"111","author":"Li","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.113313_b0050","article-title":"Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b21 signaling pathway","volume":"113","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"16","key":"10.1016\/j.intimp.2024.113313_b0055","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.3390\/molecules28166035","article-title":"Zanubrutinib ameliorates cardiac fibrosis and inflammation induced by chronic sympathetic activation","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113313_b0060","doi-asserted-by":"crossref","unstructured":"S. Zhang, X. Jia, Q. Zhang et al., Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway, J. Cell. Mol. Med. 24(2), 1658\u20131669.","DOI":"10.1111\/jcmm.14858"},{"issue":"3","key":"10.1016\/j.intimp.2024.113313_b0065","first-page":"373","article-title":"A systematic review and metaanalysis of predictors of mortality in idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"50","author":"Hannah","year":"2023","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113313_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ddg.12909","article-title":"Guidelines on dermatomyositis\u2013excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology","volume":"14","author":"Sunderk\u00f6tter","year":"2016","journal-title":"J. Dtsch. Dermatol. Ges."},{"issue":"1","key":"10.1016\/j.intimp.2024.113313_b0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-018-1737-2","article-title":"Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis","volume":"20","author":"Ishikawa","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2024.113313_b0080","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3390\/ijms24032405","article-title":"Understanding interstitial lung diseases associated with connective tissue disease (CTD-ILD): genetics, cellular pathophysiology, and biologic drivers","volume":"24","author":"Cerro Chiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6\u20137","key":"10.1016\/j.intimp.2024.113313_b0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molimm.2004.04.008","article-title":"B cell antigen receptor signaling 101","volume":"41","author":"Dal Porto","year":"2004","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113313_b0090","article-title":"Treating autoimmune-related interstitial lung disease with B cell depletion","volume":"30","author":"Liossis","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113313_b0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12931-019-1195-7","article-title":"Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis","volume":"20","author":"Heukels","year":"2019","journal-title":"Respir. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924018356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924018356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T03:44:27Z","timestamp":1729655067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924018356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"alternative-id":["S1567576924018356"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113313","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK\/NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113313"}}